DNLI
Price
$26.83
Change
-$0.00 (-0.00%)
Updated
Oct 14 closing price
16 days until earnings call
IMNN
Price
$1.03
Change
-$0.00 (-0.00%)
Updated
Oct 14 closing price
27 days until earnings call
Ad is loading...

DNLI vs IMNN

Header iconDNLI vs IMNN Comparison
Open Charts DNLI vs IMNNBanner chart's image
Denali Therapeutics
Price$26.83
Change-$0.00 (-0.00%)
Volume$778.97K
CapitalizationN/A
Imunon
Price$1.03
Change-$0.00 (-0.00%)
Volume$100.47K
CapitalizationN/A
View a ticker or compare two or three
DNLI vs IMNN Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IMNN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
DNLI vs. IMNN commentary
Oct 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a StrongBuy and IMNN is a Hold.

COMPARISON
Comparison
Oct 16, 2024
Stock price -- (DNLI: $26.83 vs. IMNN: $1.01)
Brand notoriety: DNLI and IMNN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 71% vs. IMNN: 25%
Market capitalization -- DNLI: $4.17B vs. IMNN: $15.26M
DNLI [@Biotechnology] is valued at $4.17B. IMNN’s [@Biotechnology] market capitalization is $15.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileIMNN’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • IMNN’s FA Score: 0 green, 5 red.
According to our system of comparison, DNLI is a better buy in the long-term than IMNN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 5 TA indicator(s) are bullish while IMNN’s TA Score has 3 bullish TA indicator(s).

  • DNLI’s TA Score: 5 bullish, 4 bearish.
  • IMNN’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, DNLI is a better buy in the short-term than IMNN.

Price Growth

DNLI (@Biotechnology) experienced а +0.86% price change this week, while IMNN (@Biotechnology) price change was -0.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

DNLI is expected to report earnings on Mar 03, 2025.

IMNN is expected to report earnings on Mar 27, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($4.17B) has a higher market cap than IMNN($15.3M). IMNN YTD gains are higher at: 48.529 vs. DNLI (25.023). IMNN has higher annual earnings (EBITDA): -18.66M vs. DNLI (-486.71M). DNLI has more cash in the bank: 896M vs. IMNN (5.31M). IMNN has less debt than DNLI: IMNN (1.39M) vs DNLI (48.8M). DNLI has higher revenues than IMNN: DNLI (1.27M) vs IMNN (0).
DNLIIMNNDNLI / IMNN
Capitalization4.17B15.3M27,255%
EBITDA-486.71M-18.66M2,608%
Gain YTD25.02348.52952%
P/E RatioN/AN/A-
Revenue1.27M0-
Total Cash896M5.31M16,883%
Total Debt48.8M1.39M3,513%
FUNDAMENTALS RATINGS
DNLI vs IMNN: Fundamental Ratings
DNLI
IMNN
OUTLOOK RATING
1..100
6412
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
85100
SMR RATING
1..100
9498
PRICE GROWTH RATING
1..100
4083
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMNN's Valuation (62) in the Medical Specialties industry is in the same range as DNLI (93) in the Biotechnology industry. This means that IMNN’s stock grew similarly to DNLI’s over the last 12 months.

DNLI's Profit vs Risk Rating (85) in the Biotechnology industry is in the same range as IMNN (100) in the Medical Specialties industry. This means that DNLI’s stock grew similarly to IMNN’s over the last 12 months.

DNLI's SMR Rating (94) in the Biotechnology industry is in the same range as IMNN (98) in the Medical Specialties industry. This means that DNLI’s stock grew similarly to IMNN’s over the last 12 months.

DNLI's Price Growth Rating (40) in the Biotechnology industry is somewhat better than the same rating for IMNN (83) in the Medical Specialties industry. This means that DNLI’s stock grew somewhat faster than IMNN’s over the last 12 months.

DNLI's P/E Growth Rating (98) in the Biotechnology industry is in the same range as IMNN (100) in the Medical Specialties industry. This means that DNLI’s stock grew similarly to IMNN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DNLIIMNN
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 19 days ago
80%
Bullish Trend 6 days ago
74%
Declines
ODDS (%)
Bearish Trend 6 days ago
78%
Bearish Trend 8 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IMNN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X66046.1250003194.750000
+5.08%
Bitcoin cryptocurrency
GME21.330.50
+2.40%
GameStop Corp
AAPL231.403.85
+1.69%
Apple
SPY584.324.74
+0.82%
SPDR® S&P 500® ETF Trust
TSLA219.161.36
+0.62%
Tesla

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been closely correlated with BEAM. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
-4.18%
BEAM - DNLI
66%
Closely correlated
+7.56%
NTLA - DNLI
63%
Loosely correlated
+5.06%
ALEC - DNLI
58%
Loosely correlated
+2.08%
JANX - DNLI
57%
Loosely correlated
-0.36%
RCKT - DNLI
55%
Loosely correlated
-1.11%
More

IMNN and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNN has been loosely correlated with VANI. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNN jumps, then VANI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNN
1D Price
Change %
IMNN100%
-0.98%
VANI - IMNN
36%
Loosely correlated
+0.88%
STOK - IMNN
30%
Poorly correlated
+7.77%
DNLI - IMNN
30%
Poorly correlated
-4.18%
DTIL - IMNN
29%
Poorly correlated
-0.34%
IVVD - IMNN
28%
Poorly correlated
-2.17%
More